ReviewCureus2025
Comparative Effectiveness of Pharmacological and Non-pharmacological Interventions for Hypertension Management: A Systematic Review and Meta-Analysis.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertension is a major global health burden, which is strongly linked to stroke, heart disease, kidney failure, and premature death. Pharmacological therapies remain the cornerstone of management, but adherence, cost, and side effects pose significant challenges. Lifestyle interventions such as diet, exercise, and stress reduction provide comparable benefits with fewer risks. We conducted a PRISMA-guided systematic review (2015-2025) across PubMed and Google Scholar. The eligible studies included adult hypertensive patients receiving pharmacological or non-pharmacological interventions. Our review of 21 studies (n > 63,000) showed consistent blood pressure (BP) benefits across intervention types. The pooled systolic BP reduction was -6.95 mmHg (95% CI: 4.79-10.09) across all the studies, with the pharmacological interventions (-6.83 mmHg), non-pharmacological (-6.03 mmHg), and combined (-8.37 mmHg) interventions yielding comparable effects. The diastolic reductions were greatest with the non-pharmacological interventions (-6.77 mmHg), compared with pharmacological (-2.52 mmHg) and combined (-3.34 mmHg). The target BP achievement was highest with pharmacological therapy (67.8%), followed by the combined (58.9%) and the non-pharmacological (26.4%) approach only. The mortality was lower with pharmacological management (3.7%) compared to combined interventions (14%, single study). The secondary outcomes included modest BMI reduction (-0.80 kg/m²) and cholesterol lowering (-7.04 mg/dL), with the greatest effects from combined strategies. This study shows that both pharmacological and non-pharmacological interventions effectively reduce BP, with the combined strategies showing the greatest impact. Pharmacological therapies achieved superior target control and lower mortality, while lifestyle changes improved metabolic outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.